The effects of PRP with reduced Leukocyte content therapy on chronic knee osteoarthritis

Pishtaz Teb Zaman CO.0 个研究点目标入组 15 人开始时间: 待定最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Men and women between the ages of 18 and 75 with OA diagnosis based on the American College of Rheumatology
•Analog scale of knee pain (VAS) equal to or greater than 2.5
•People with at least 4 months of history of pain or swelling in one or both knees
•Radiological classification scale Kellgren-Lawrence 1 or 2
•The availability of individual during the study period
•BMI Between 20 and 35

•People under the age of 18 and over 75 years
•Pregnant women or women who are breastfeeding
•People with malignancy,People with severe heart disease, uncontrolled diabetes mellitus, rheumatoid arthritis, hemorrhagic diseases, history of anemia, arthritis, fibromyalgia and chronic fatigue syndrome
•People with acetaminophen or vicodin addiction or a history of drug misuse
•History of cortisone injections in the last 6 weeks
•The use of non-steroidal anti-inflammatory drugs 1 week ago
•Having hemoglobin less than 11 g / dl and platelet count less than 150000 / mµ
•The use of inhibitors of platelet aggregation and anti-coagulation such as heparin
•History of knee surgery in the last 3 months
•Extraordinary deformation (varus >5?, valgus >5?)

发起方

Pishtaz Teb Zaman CO.